Radiotherapy has an important role to play in the fight against cancer, with around 50% of patients receiving radiotherapy as part of their treatment.
Our Advanced Radiotherapy research aims to embrace technological advances and develop biomarkers to predict the effectiveness of different types of radiation and drug-radiation combinations, whilst minimising the risk of long-term side effects.
We have world-leading clinical and experimental radiation facilities, including the Dalton Nuclear Institute. Our radiotherapy facility is already the largest in Europe with 8,500 patients treated and 120,000 radiation fractions delivered annually.
Cancer patients in the UK now have access to high energy proton therapy, with the first NHS Proton Beam Therapy Centre opened in December 2018 to treat around 750 of the most complicated cancer patients each year.
Manchester is also the only UK site with three state-of-the-art techniques: Stereotactic Ablative Radiotherapy, a Magnetic Resonance Imaging scanner combined with a radiation machine (MR-linac) and high energy Proton Therapy.